(Q33906011)

English

Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Aung T

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Wong HT

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yip CC

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leong JY

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chan YH

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chew PT

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1178-1183

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Number of people with glaucoma worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in the epidemiology and population-based screening of primary angle-closure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900073-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(00)00073-7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33906011&oldid=1991133320"